Stay updated on Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Sign up to get notified when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.

Latest updates to the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page
- CheckyesterdayChange DetectedNo significant changes detected in the page content or structure; essential study information remains the same.SummaryDifference0.4% 
- Check8 days agoNo Change Detected
- Check30 days agoChange DetectedCore page metadata updated: new contact details added and version bumped from v3.0.2 to v3.2.0.SummaryDifference0.1% 
- Check31 days agoChange DetectedUpdated revision to v3.1.0 and added new contact details (phone numbers and emails); removed the previous revision tag v3.0.2.SummaryDifference0.1% 
- Check45 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2% 
- Check53 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.2% 
- Check60 days agoChange DetectedThe web page has been updated to include a new facility name and location, as well as specific information regarding HIV and pregnancy, while removing previous location details and references to vedolizumab as a gastrointestinal agent.SummaryDifference5% 
Stay in the know with updates to Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.